Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu’s arteritis
Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is reg...
Saved in:
Published in | Arthritis research & therapy Vol. 27; no. 1; pp. 11 - 15 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
20.01.2025
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK.
Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients.
The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort.
Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury. |
---|---|
AbstractList | Abstract Background Advances in treatment have swiftly alleviated systemic inflammation of Takayasu’s arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Methods Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. Results The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Conclusion Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury. Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury. Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury. Background Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Methods Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. Results The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Conclusion Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury. Keywords: Takayasu's arteritis, Vascular remodeling, Vascular smooth muscle cells, Exosome, miRNA Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK.BACKGROUNDAdvances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK.Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients.METHODSSerum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients.The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort.RESULTSThe coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort.Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury.CONCLUSIONOur study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury. |
ArticleNumber | 11 |
Audience | Academic |
Author | Li, Jing Guo, Shuning Pang, Shurui Tian, Xinping Li, Jiehan |
Author_xml | – sequence: 1 givenname: Shuning surname: Guo fullname: Guo, Shuning – sequence: 2 givenname: Jiehan surname: Li fullname: Li, Jiehan – sequence: 3 givenname: Shurui surname: Pang fullname: Pang, Shurui – sequence: 4 givenname: Jing surname: Li fullname: Li, Jing – sequence: 5 givenname: Xinping surname: Tian fullname: Tian, Xinping |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39833857$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks9u1DAQxi1URNuFF-CAInHhkuL_cU6oqgpUqoSEytmaOJPFJYkXO1t1b7wGr9cnqXfToi5CyIozsb_5aSbzHZODMYxIyGtGTxgz-n1iglaqpDw_QuaIPSNHTFam1ELzgyfxITlO6ZpSzmsuX5BDURshjKqOiD-_DSkMWAz-a8nqGkq1KobQrnuYsC1uILkcxiJiPsTej8sCxrbwY9fDMMAU4mb74fspwuTDWISuuIIfsIG0vvv1OxUQJ4x-8ukled5Bn_DVw3tBvn08vzr7XF5--XRxdnpZOiX0VFYMQLWUa9cY1QhoDJVIu65RnTSUNlTUFLQE0ymsTFsJpo0UDGTLHTBaiQW5mLltgGu7in6AuLEBvN0dhLi0uSbverTIKiUUZ6rhVMo6g7Q04HSNgmrsZGZ9mFmrdTNg63DMbfZ70P2b0X-3y3BjGasyUPJMePdAiOHnGtNkB58c9j2MGNbJCqYqpaTU28LfztIl5NryTw0Z6bZye2q4zBPe7gty8g9VXi0O3mWD5FngfsKbpz38Kf7RA1lgZoGLIaWInXV-2g0zk31vGbVbu9nZbjbbze7sZllO5X-lPtL_k3QP-w7XMA |
CitedBy_id | crossref_primary_10_3390_ijms26072881 |
Cites_doi | 10.1161/CIRCULATIONAHA.120.049922 10.1371/journal.pone.0206239 10.3390/diagnostics12102565 10.1007/s11926-019-0848-3 10.1111/eci.13697 10.1016/j.ejrad.2013.06.019 10.1016/j.ijcard.2017.12.066 10.3390/ijms22147284 10.1096/fj.201701558R 10.1093/nar/gkaa1039 10.3390/jcdd8120187 10.1253/circj.CJ-12-0131 10.1002/jcb.28631 10.1002/adma.201802896 10.1093/nar/gkac519 10.1016/j.gene.2017.03.032 10.1097/MD.0000000000007558 10.1002/acr.24117 10.1002/art.1780330811 10.1093/rheumatology/kex333 10.7150/thno.46143 10.1007/s00018-023-04793-w 10.1016/j.amjms.2017.08.018 10.1016/j.gene.2019.144193 10.1016/j.bbrc.2018.02.051 10.1161/01.CIR.0000089089.42153.5E 10.1161/CIRCULATIONAHA.106.619056 10.1161/01.CIR.0000090689.69973.B1 10.1161/ATVBAHA.119.312787 10.1055/s-0029-1225668 10.1016/j.cellsig.2018.08.019 10.1038/s41572-021-00327-5 10.1186/s12964-022-00949-6 10.3389/fimmu.2021.811485 10.1111/jcmm.14060 10.1016/j.ijcard.2015.12.006 10.1093/nar/gkt1248 10.1016/S0140-6736(23)01736-1 10.7326/0003-4819-120-11-199406010-00004 10.1016/j.cjca.2016.02.070 10.3389/fimmu.2022.859502 10.2478/rir-2023-0002 10.1096/fj.201901548R |
ContentType | Journal Article |
Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. The Author(s) 2025 2025 |
Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: The Author(s) 2025 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1186/s13075-025-03475-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 |
EndPage | 15 |
ExternalDocumentID | oai_doaj_org_article_e17535215b20449684648ac69e306ef4 PMC11744942 A824347824 39833857 10_1186_s13075_025_03475_1 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: National High Level Hospital Clinical Research Funding grantid: 2022-PUMCH-A-006 – fundername: National High Level Hospital Clinical Research Funding grantid: 2022-PUMCH-B-013 – fundername: CAMS Innovation Fund for Medical Sciences grantid: 2021-I2M-1-005 |
GroupedDBID | --- .GJ 0R~ 23N 2WC 4.4 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ INH INR ITC KQ8 M1P O5R O5S O9- PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c536t-71aa5d026cb85b3ab804e0ffb5f4800b0390a64a8f5e78d73168431a4d2ca1073 |
IEDL.DBID | DOA |
ISSN | 1478-6362 1478-6354 |
IngestDate | Wed Aug 27 01:26:06 EDT 2025 Thu Aug 21 18:40:16 EDT 2025 Mon Jul 21 11:54:02 EDT 2025 Tue Jun 17 22:00:03 EDT 2025 Tue Jun 10 20:55:08 EDT 2025 Mon Jul 21 05:33:57 EDT 2025 Tue Jul 01 04:01:04 EDT 2025 Thu Apr 24 23:08:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Vascular remodeling miRNA Takayasu’s arteritis Exosome Vascular smooth muscle cells |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c536t-71aa5d026cb85b3ab804e0ffb5f4800b0390a64a8f5e78d73168431a4d2ca1073 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/e17535215b20449684648ac69e306ef4 |
PMID | 39833857 |
PQID | 3157554467 |
PQPubID | 23479 |
PageCount | 15 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e17535215b20449684648ac69e306ef4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11744942 proquest_miscellaneous_3157554467 gale_infotracmisc_A824347824 gale_infotracacademiconefile_A824347824 pubmed_primary_39833857 crossref_citationtrail_10_1186_s13075_025_03475_1 crossref_primary_10_1186_s13075_025_03475_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-01-20 |
PublicationDateYYYYMMDD | 2025-01-20 |
PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Arthritis research & therapy |
PublicationTitleAlternate | Arthritis Res Ther |
PublicationYear | 2025 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 3475_CR40 3475_CR20 3475_CR42 3475_CR41 3475_CR22 3475_CR44 3475_CR21 3475_CR43 3475_CR24 3475_CR23 3475_CR26 3475_CR25 3475_CR28 3475_CR27 3475_CR29 3475_CR31 3475_CR30 3475_CR11 3475_CR33 3475_CR10 3475_CR32 3475_CR13 3475_CR35 3475_CR12 3475_CR34 3475_CR2 3475_CR15 3475_CR37 3475_CR1 3475_CR14 3475_CR36 3475_CR4 3475_CR17 3475_CR39 3475_CR3 3475_CR16 3475_CR38 3475_CR6 3475_CR19 3475_CR5 3475_CR18 3475_CR8 3475_CR7 3475_CR9 |
References_xml | – ident: 3475_CR8 doi: 10.1161/CIRCULATIONAHA.120.049922 – ident: 3475_CR17 doi: 10.1371/journal.pone.0206239 – ident: 3475_CR40 doi: 10.3390/diagnostics12102565 – ident: 3475_CR1 doi: 10.1007/s11926-019-0848-3 – ident: 3475_CR20 doi: 10.1111/eci.13697 – ident: 3475_CR36 doi: 10.1016/j.ejrad.2013.06.019 – ident: 3475_CR42 doi: 10.1016/j.ijcard.2017.12.066 – ident: 3475_CR3 doi: 10.3390/ijms22147284 – ident: 3475_CR27 doi: 10.1096/fj.201701558R – ident: 3475_CR18 doi: 10.1093/nar/gkaa1039 – ident: 3475_CR41 doi: 10.3390/jcdd8120187 – ident: 3475_CR44 doi: 10.1253/circj.CJ-12-0131 – ident: 3475_CR30 doi: 10.1002/jcb.28631 – ident: 3475_CR12 doi: 10.1002/adma.201802896 – ident: 3475_CR21 doi: 10.1093/nar/gkac519 – ident: 3475_CR28 doi: 10.1016/j.gene.2017.03.032 – ident: 3475_CR38 doi: 10.1097/MD.0000000000007558 – ident: 3475_CR2 doi: 10.1002/acr.24117 – ident: 3475_CR13 doi: 10.1002/art.1780330811 – ident: 3475_CR23 doi: 10.1093/rheumatology/kex333 – ident: 3475_CR24 doi: 10.7150/thno.46143 – ident: 3475_CR15 doi: 10.1007/s00018-023-04793-w – ident: 3475_CR32 doi: 10.1016/j.amjms.2017.08.018 – ident: 3475_CR31 doi: 10.1016/j.gene.2019.144193 – ident: 3475_CR29 doi: 10.1016/j.bbrc.2018.02.051 – ident: 3475_CR35 doi: 10.1161/01.CIR.0000089089.42153.5E – ident: 3475_CR34 doi: 10.1161/CIRCULATIONAHA.106.619056 – ident: 3475_CR43 doi: 10.1161/01.CIR.0000090689.69973.B1 – ident: 3475_CR9 doi: 10.1161/ATVBAHA.119.312787 – ident: 3475_CR37 doi: 10.1055/s-0029-1225668 – ident: 3475_CR7 doi: 10.1016/j.cellsig.2018.08.019 – ident: 3475_CR10 doi: 10.1038/s41572-021-00327-5 – ident: 3475_CR11 doi: 10.1186/s12964-022-00949-6 – ident: 3475_CR4 doi: 10.3389/fimmu.2021.811485 – ident: 3475_CR25 doi: 10.1111/jcmm.14060 – ident: 3475_CR39 doi: 10.1016/j.ijcard.2015.12.006 – ident: 3475_CR19 doi: 10.1093/nar/gkt1248 – ident: 3475_CR22 doi: 10.1016/S0140-6736(23)01736-1 – ident: 3475_CR14 doi: 10.7326/0003-4819-120-11-199406010-00004 – ident: 3475_CR33 doi: 10.1016/j.cjca.2016.02.070 – ident: 3475_CR5 doi: 10.3389/fimmu.2022.859502 – ident: 3475_CR6 doi: 10.2478/rir-2023-0002 – ident: 3475_CR16 – ident: 3475_CR26 doi: 10.1096/fj.201901548R |
SSID | ssj0022924 |
Score | 2.4581647 |
Snippet | Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing... Background Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the... Abstract Background Advances in treatment have swiftly alleviated systemic inflammation of Takayasu’s arteritis (TAK), while subclinical vascular inflammation... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 11 |
SubjectTerms | Adult Analysis Apoptosis Care and treatment Cell Movement Cell Proliferation Cells, Cultured Coculture Techniques Diagnosis Exosome Exosomes - genetics Exosomes - metabolism Female Genetic aspects Genetic markers Humans Inflammation - genetics Inflammation - metabolism Inflammation - pathology Male MicroRNA MicroRNAs - genetics MicroRNAs - metabolism Middle Aged miRNA Muscle, Smooth, Vascular - metabolism Muscle, Smooth, Vascular - pathology Myocytes, Smooth Muscle - metabolism Myocytes, Smooth Muscle - pathology Phenotype Takayasu Arteritis - genetics Takayasu Arteritis - metabolism Takayasu Arteritis - pathology Takayasu's arteritis Vascular remodeling Vascular Remodeling - genetics Vascular Remodeling - physiology Vascular smooth muscle cells |
Title | Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu’s arteritis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39833857 https://www.proquest.com/docview/3157554467 https://pubmed.ncbi.nlm.nih.gov/PMC11744942 https://doaj.org/article/e17535215b20449684648ac69e306ef4 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9swEBbtFkovpe96uw0qFHooZiPrYfmYLVmWwi5l2UBuQk8aurGXdQLtbf9G_15_SUeyHWIK7aWHmCSSsayZ0TeDRt8g9J67UpuiBM_NGZszYUNupBA5K4MnmmrAiHjA-fxCnC3Y5yVf7pX6ijlhHT1wN3HHPlJJAsZwU0wZqwTgJZPaisqDs-tDYgIFzBuCqT7UKiCsGI7ISHHcwkpdxpPI8KEMvpERDCW2_j_X5D1QGidM7iHQ6RP0uHcd8awb8lN0z9fP0MPzfnP8OVrNvzdts_Z4vbqMmR065zd43bhYoMs7POSc4lufyt8AZmFdOwwqBlqxTrvt8cfqumfSxU3AV_qb_qHb7a-7ny1O6Z-RA-kFWpzOrz6d5X0lhdxyKjZ5SbTmDsItayQ3VBs5ZX4aguGBgcdoprSaasG0DNyX0qVqVuBZaOYKqyFApC_RQd3U_jXCwTlTuUp7MF4mrZUyOEmsYB6AnnifITJMrLI9zXisdnGtUrghheqEoUAYKglDkQx93N1z05Fs_LX3SZTXrmckyE5_gNqoXm3Uv9QmQx-itFU0Yxie1f1pBHjJSIilZrJg8Di4Zuho1BPMz46a3w36omJTzFmrfbNtFSXgCnMIt8sMver0ZzdmWklKJYcWOdKs0UuNW-rV18T-TSCGZBUrDv_HNLxBj4pkFQSWyyN0sLnd-rfgZW3MBN0vl-UEPTiZX3y5nCTzguuimP0G6fAmBg |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosome+miR-199a-5p+modulated+vascular+remodeling+and+inflammatory+infiltration+of+Takayasu%E2%80%99s+arteritis&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Shuning+Guo&rft.au=Jiehan+Li&rft.au=Shurui+Pang&rft.au=Jing+Li&rft.date=2025-01-20&rft.pub=BMC&rft.eissn=1478-6362&rft.volume=27&rft.issue=1&rft.spage=1&rft.epage=15&rft_id=info:doi/10.1186%2Fs13075-025-03475-1&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e17535215b20449684648ac69e306ef4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon |